What's the purpose of this trial?
This clinical trial tests how well a pain management intervention preparatory to a future pragmatic trial works in rural dwelling and Hispanic cancer survivors. Cancer pain is a key case study in health disparities in the United States. Cancer pain is prevalent, under treated, and remains a major cause of suffering, impairment, and disability for millions of Americans. Individual pain interventions and care models show promise for cancer pain in controlled settings. Hispanic and rural-dwelling cancer survivors stand to benefit the most from electronic health record innovations, as each of these health disparities populations experience profound disparities in pain outcomes, including marked under- and over-prescribing of opioids. Additionally, Hispanics not only comprise a steadily growing proportion of cancer survivors, but are also increasingly immigrating to rural communities, potentially placing them at "double risk" for poor outcomes. This trial will allow for the refinement of pain management intervention components that could help the management of cancer-related pain in rural dwelling and Hispanic cancer survivors.
This trial is currently open and accepting patients.
What will happen during the trial?
You may be able to join this trial if you:
The following criteria is a partial list of reasons why patients may be
eligible to participate in this clinical trial. Further evaluation with a medical professional is
required.
Inclusion Criteria:
* A qualifying liquid or solid cancer diagnosis with visits at a participating Mayo site
* Age 18+
* Numerical rating scale (NRS) pain score of a 5+ out of 10
* Pain that developed (onset) or significantly worsened since cancer diagnosis
* Malignant hematology including:
* Lymphoma
* Myeloma
* Chronic leukemias
Exclusion Criteria:
* Patient Health Questionnaire (PHQ) 8 score of 10 or more
* Life expectancy less than 12 months
* Hospice enrollment
* Acute leukemias
Additional Trial Information
Pilot Trial
Enrollment: 140 patients (estimated)
View More